Latest news and events
Latest News from the Partnership
2020.01.09 | People , Knowledge exchange
Introducing Group Leader Esa Pitkänen
Esa Pitkänen is a FIMM-EMBL Group Leader at the Institute for Molecular Medicine Finland at the University of Helsinki. He specializes in computational cancer genetics, machine learning and bioinformatics. In this interview Esa shares his keen interests and sheds a light on how machine learning and computational analyses can be applied to…
2020.01.07 | News from the management, People
The Nordic EMBL Partnership is now seeking PHD students in Molecular Medicine
As part of the joint Nordic EMBL Partnership call for PhD students, we are seeking outstanding candidates for PhD positions at DANDRITE, FIMM, NCMM and MIMS.
2019.12.19 | News from the management, People
Scientific Manager for Molecular Infection Medicine Sweden (MIMS)
An exciting new position at MIMS
2019.12.12 | People , Conference
PhD students from the Nordic EMBL Partnership node NCMM, attend EMBL PhD symposium in Heidelberg
Nine PhD students from various NCMM groups attended this year's EMBL PhD Symposium in Heidelberg, Germany. Two students presented flash talks as part of the main program, and Karolina Spustová from the Gözen group was awarded a prize for the best poster.
2019.12.10 | Awards
Poul Nissen receives the Lundbeck Foundation's professor grant
The Lundbeck Foundation is awarding grants worth DKK 232 million (USD 34 million) to six leading neuroscientists. The LF Professorships programme is the Foundation’s largest grant allocation to date.
2019.11.18 | Research news, People
The FinnGen Research Project
The FinnGen Research project was launched in Finland in 2017 and is among the very first personalized medicine projects that combines genome information with digital health care data. Professor Aarno Palotie is a Research Director at FIMM and leads the FinnGen study. Palotie’s main focus is to better understand the genetic mechanisms in common…
2019.10.09 | People , Events
Science by the Seafront: researchers from around the world connected at the annual EMBL Partnership Conference “Perspectives in Translational Medicine”.
Hosted by EMBL Barcelona, located at the Barcelona Biomedical Research Park, the 3rd annual EMBL Partnership Conference took place from 25-27 September in Barcelona, Spain.
2019.09.09 | People , Research news
Elisabeth Widén, Group Leader, FIMM
Dr Widén is a physician by training, with an interest in genomics and the genetic contribution to complex diseases. Dr Widén initially focused her research on puberty and the genes that influence this process. In recent years, however, Dr Widén’s interest has now shifted towards implementing genomic research into medical practice.
2019.09.02 | People , Awards
Honorary doctorate 2019: Professor Mark Joseph Daly
Professor Mark Joseph Daly, Director of the Institute of Molecular Medicine Finland (FIMM), the Finnish node of the Nordic EMBL Partnership is awarded Aarhus University’s honorary doctorate at the Faculty of Health.
2019.08.21 | People , Research news
Behind the Scenes: Dr Sadegh Nabavi, Group Leader at DANDRITE
Nabavi’s group focuses on memory formation and consolidation at the synaptic and circuit levels. Recently, Dr. Sadegh Nabavi had his group leader position extended for a further four years. In our latest Behind the Scenes article, Dr Nabavi discusses his research and his curiosity and passion for neuroscience.
Upcoming Partnership Events
- Mon 20 Jan
- 09:00-15:00 | EMBL Heidelberg, Germany
Deap Learning for Image Analysis
EMBL Course aimed at both core facility staff and research scientists. - Tue 21 Jan
- 12:00-13:45 | European Bioinformatics Institute (EMBL-EBI) - Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom
Introduction to RNA-Seq and Functional Interpretation
EMBL Course - Wed 22 Jan
- 09:00-17:15 | Helsinki, Finland
Modern GWAS meets Classic HLA and latest advances in complex disease genetics
Course organised by Centre of Excellence in Complex Disease Genetics (CoECDG) Registration open until January 14th, 2020
News on publications
2019.11.08 | Publication, Knowledge exchange
Targeted Gene Modification in Animal Pathogenic Chlamydia
Researchers at Umeå University (Sweden), in collaboration with researchers at the University of Maryland and Duke University (USA), now for the first time successfully performed targeted gene mutation in the zoonotic pathogen Chlamydia caviae.
2019.10.30 | Publication, Knowledge exchange, People
New article from Irep Gözen: how did the first cell division event take place?
NCMM group leader Irep Gözen recently published a perspectives article in ACS Nano, where she presents a new hypothesis for how cells were first able to divide on the early earth.
2019.10.14 | Publication, Research news, Knowledge exchange, People
Yonehera group at DANDRITE have identified a new circuit mechanism in mammalian retinal motion computation
Latest research from the group led by Keisuke Yonehara at DANDRITE has recently been published in peer-reviewed scientific journal “Current Biology”. The study is about the space-time wiring between a type of motion-sensitive cells that project to the brain for gaze stabilization and local excitatory cells in the mouse retina.
2019.09.11 | Publication, Research news
Research from the Sekulic Group provides new molecular insights into the structure and function of the centromer
New work from the group led by Nikolina Sekulic at NCMM has been published in EMBO Reports. The study sheds light on the structure of nucleosomes contained within the centromere; findings that will help to improve our understanding of the important molecular events that drive cell mitosis.
2019.07.28 | Publication
Miniaturized version of ribosome found in microsporidia
A research team lead by MIMS/SciLifeLab research group leader Jonas Barandun uses cryo-electron microscopy to provide near atomic details of the smallest known eukaryotic cytoplasmic protein synthesis machine, the microsporidian ribosome.
2019.06.13 | Publication
DrugComb, a one-stop solution to all your cancer drug combination data analysis needs
Assistant Professor Jing Tang, a principal investigator of the Network Pharmacology group at FIMM and at the UH Faculty of Medicine has led the development of DrugComb, an open resource for harmonizing cancer drug combination studies. Dr. Tang hopes that DrugComb would become a collaborative data analysis platform that would bring forth more…
2019.03.15 | Publication
Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer.
The study was conducted by research groups lead by Jing Tang at the Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE) and the Faculty of Medicine and Caroline Heckman at FIMM. The results were recently published in PLOS Computational Biology.
